25.02.2024

Overdoses Involving Xylazine Mixed with Fentanyl

More news about the topic

Xylazine is a non-opioid sedative/tranquilizer that has been found in the US illegal drug supply and linked to overdose deaths. It is not approved for use in people and can be life-threatening and especially dangerous when combined with opioids like fentanyl. Due to its impact on the opioid crisis, xylazine mixed with fentanyl has been declared an emerging threat by the White House's Office of National Drug Control Policy (ONDCP).

To offer the most up to date information and guidance to clinicians on this emerging public health threat, DOP and presenters from Rutgers University and Brown University will host a COCA Call/Webinar. They will discuss the epidemiology of overdoses involving xylazine mixed with fentanyl, the current understanding of health risks related to these overdoses, and acute treatment strategies. Presenters will also review the state of laboratory testing, outline potential harm reduction activities, and provide an example of an ongoing public health and clinical partnership to mitigate harms associated with the use of xylazine mixed with fentanyl. Free continuing education (CE) credit is available for the call.

Date: Thursday, February 29th
Time: 02:00 PM – 03:00 PM EST

Get more information

Ein Service des deutschen Präventionstages.
www.praeventionstag.de